Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Share Price

Price 215.00p on 04-07-2025 at 18:50:06
Change 0.00p 0%
Buy 220.00p
Sell 210.00p
Buy / Sell FARN Shares
Last Trade: Sell 1,285.00 at 211.00p
Day's Volume: 7,958
Last Close: 215.00p
Open: 215.00p
ISIN: FI4000153309
Day's Range 210.00p - 210.00p
52wk Range: 94.00p - 265.00p
Market Capitalisation: £246m
VWAP: 210.83853p
Shares in Issue: 117m

Faron Pharmaceuticals (FARN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,285 211.00p Ordinary
14:00:35 - 04-Jul-25
Sell* 1,285 210.00p Uncrossing Trade
14:00:01 - 04-Jul-25
Sell* 647 211.00p Ordinary
11:36:07 - 04-Jul-25
Sell* 500 212.50p Ordinary
14:51:46 - 03-Jul-25
Sell* 1,153 212.50p Ordinary
11:21:53 - 03-Jul-25
Sell* 599 212.50p Ordinary
10:01:05 - 03-Jul-25
Buy* 1 220.00p SI Trade
08:27:59 - 03-Jul-25
Buy* 454 219.00p Ordinary
14:44:36 - 02-Jul-25
Sell* 1,100 213.10p Ordinary
13:16:50 - 02-Jul-25
Buy* 110 220.00p Ordinary
12:27:52 - 02-Jul-25
See more Faron Pharmaceuticals trades

Faron Pharmaceuticals (FARN) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Jul 2025 (Fri) 215.00 210.00 210.00 215.00 7,958
3rd Jul 2025 (Thu) 215.00 215.00 215.00 215.00 2,753
2nd Jul 2025 (Wed) 202.50 215.00 202.50 215.00 6,116
1st Jul 2025 (Tue) 202.50 202.50 202.50 202.50 2,924
30th Jun 2025 (Mon) 190.00 202.50 195.00 202.50 49,560
27th Jun 2025 (Fri) 185.00 190.00 185.00 190.00 10,696
26th Jun 2025 (Thu) 192.50 192.50 177.50 185.00 56,749
25th Jun 2025 (Wed) 195.00 195.00 192.50 192.50 18,063
24th Jun 2025 (Tue) 197.50 197.50 195.00 195.00 6,855
23rd Jun 2025 (Mon) 202.50 202.50 197.50 197.50 2,944
20th Jun 2025 (Fri) 202.50 202.50 202.50 202.50 1,356
19th Jun 2025 (Thu) 220.00 220.00 202.50 202.50 36,702
18th Jun 2025 (Wed) 222.50 230.00 215.00 215.00 16,362
17th Jun 2025 (Tue) 222.50 225.00 222.50 222.50 1,725
16th Jun 2025 (Mon) 222.50 235.00 222.50 222.50 5,240
13th Jun 2025 (Fri) 227.50 230.00 230.00 230.00 26,381
12th Jun 2025 (Thu) 227.50 227.50 227.50 227.50 1,882
11th Jun 2025 (Wed) 225.00 235.00 227.50 227.50 3,721
10th Jun 2025 (Tue) 217.50 225.00 217.50 225.00 4,458
9th Jun 2025 (Mon) 215.00 217.50 215.00 217.50 6,142
6th Jun 2025 (Fri) 215.00 215.00 215.00 215.00 5,058
5th Jun 2025 (Thu) 225.00 225.00 212.50 215.00 36,474
See more Faron Pharmaceuticals price history

Faron Pharmaceuticals (FARN) Regulatory News

Date Source Headline
3rd Mar 2025 12:05 pm RNS FDA Grants Orphan Drug Designation
28th Feb 2025 12:00 pm RNS Notice of Annual General Meeting
27th Feb 2025 7:30 am RNS Positive EMA Opinion on Orphan Drug Designation
27th Feb 2025 7:15 am RNS Annual Report 2024 published
27th Feb 2025 7:00 am RNS Financial Statement 1 January to 31 December 2024
19th Feb 2025 10:00 am RNS Notice of Financial Statement and Annual Report
14th Feb 2025 12:00 pm RNS Holding(s) in Company
11th Feb 2025 7:30 am RNS Change of Broker
6th Feb 2025 3:00 pm RNS Holding(s) in Company
6th Feb 2025 7:00 am RNS Results of Oversubscribed Placing
See more Faron Pharmaceuticals regulatory news

Faron Pharmaceuticals (FARN) Share News

IN BRIEF: Faron Pharmaceuticals Chair Tuomo Patsi adds to shareholding

2nd Jul 2025 13:23

Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Non-Executive Chair Tuomo Patsi buys 21,500 ordinary shares at EUR2.435 per share on Monday for a total of EUR52,353. Brings Patsi's shareholding in Faron to 53,265 shares, with 0.05% of company voting rights. Read More

IN BRIEF: Faron Pharmaceuticals appoints new chief business officer

21st May 2025 12:41

Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Appoints Ralph Hughes as chief business officer, effective from next Wednesday. Notes Hughes' prior experience as senior vice president at PharmaVentures, and his extensive experience in commercial due diligence, market access and the business development process. Adds that he will be part of the management team and the business development team. "We are delighted to have such an experienced pharmaceutical market access and strategic commercial development expert to join us as the new CBO", says Chief Executive Juho Jalkanen. "Ralph's proven track record in biopharma leadership and his experience align perfectly with our corporate development efforts and strategic growth initiatives." Read More

UK shareholder meetings calendar - next 7 days

14th Mar 2025 14:09

Read More

UK earnings, trading statements calendar - next 7 days

20th Feb 2025 14:16

Read More

Faron Pharmaceuticals raises EUR12 million from oversubscribed placing

6th Feb 2025 11:41

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it has raised EUR12 million from an oversubscribed placing ahead of upcoming trial results. Read More

See more Faron Pharmaceuticals news
FTSE 100 Latest
Value8,822.91
Change-0.29

Login to your account

Forgot Password?

Not Registered